- Home
- GLPI vs RDY Comparison
GLPI vs RDY Comparison
Compare GLPI & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- RDY
- Stock Information
- Founded
- GLPI 2013
- RDY 1984
- Country
- GLPI United States
- RDY India
- Employees
- GLPI N/A
- RDY N/A
- Industry
- GLPI Real Estate Investment Trusts
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- GLPI Real Estate
- RDY Health Care
- Exchange
- GLPI Nasdaq
- RDY Nasdaq
- Market Cap
- GLPI 12.9B
- RDY 12.1B
- IPO Year
- GLPI N/A
- RDY N/A
- Fundamental
- Price
- GLPI $48.05
- RDY $14.23
- Analyst Decision
- GLPI Buy
- RDY Strong Buy
- Analyst Count
- GLPI 16
- RDY 2
- Target Price
- GLPI $52.33
- RDY $16.95
- AVG Volume (30 Days)
- GLPI 1.7M
- RDY 1.3M
- Earning Date
- GLPI 10-23-2025
- RDY 07-23-2025
- Dividend Yield
- GLPI 6.53%
- RDY 0.50%
- EPS Growth
- GLPI N/A
- RDY 2.20
- EPS
- GLPI 2.61
- RDY 0.79
- Revenue
- GLPI $1,565,067,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- GLPI $5.19
- RDY $7.61
- Revenue Next Year
- GLPI $3.54
- RDY $1.89
- P/E Ratio
- GLPI $18.32
- RDY $18.12
- Revenue Growth
- GLPI 5.38
- RDY 15.86
- 52 Week Low
- GLPI $44.48
- RDY $12.26
- 52 Week High
- GLPI $52.60
- RDY $16.77
- Technical
- Relative Strength Index (RSI)
- GLPI 60.97
- RDY 47.61
- Support Level
- GLPI $47.66
- RDY $14.08
- Resistance Level
- GLPI $48.27
- RDY $14.59
- Average True Range (ATR)
- GLPI 0.51
- RDY 0.18
- MACD
- GLPI 0.23
- RDY 0.06
- Stochastic Oscillator
- GLPI 93.34
- RDY 57.73
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.